Clinical trial
French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome
NCT05308927 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome
- Lead sponsor
- Novo Nordisk A/S
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- March 16, 2022
- Completion date
- March 17, 2028
- Enrollment
- 221 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.